Research

Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography

From the abstract: Low-dose computed tomography (LDCT) for lung cancer screening is effective, although most eligible people are not being screened. Tools that provide personalised future cancer risk assessment could focus approaches toward those most likely to benefit. We hypothesised that a deep learning model assessing the entire volumetric LDCT data could be built to predict individual risk without requiring additional demographic or clinical data.

Details

PUBLICATION DATE
12
January
2023
SOURCE
Journal of Clinical Oncology
RELATED PROGRAMME
LINK TO PUBLICATION